Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals | COVID-19 Impact Analysis

Global Electrical Stimulation Devices Market $7.3 Billion by 2027

The global market for electrical stimulation devices expected to attain $7.3 billion by 2027, growing at a CAGR of 4.8% over the forecast period, driven by increasing prevalence of chronic diseases, growing geriatric population, launch of novel and advanced products, and technologies in the recent years.

  • The global neuromodulation devices market is supported by significant ongoing advancements in technology and increasing prevalence of the epilepsy, migraine, spinal cord injuries, Parkinson’s disease, and urinary incontinence disorders.
  • The global pain management devices market is boosted by increasing prevalence  of chronic neuropathic pain among the growing elderly and obese populations.
Global Electrical Stimulation Devices Market

Electrical stimulation devices (ESD) or electrical muscle stimulators are essentially electrotherapy devices that are specifically designed to cause muscle contraction via electrical
impulses. Recently,  Slendertone Flex marketed by BMR NeuroTech, Inc., has been cleared by FDA for toning, strengthening and firming abdominal muscles.

  • Damage to the central nervous system (CNS) due to injury or disease, in conjunction with other health problems (e.g., muscle atrophy, joint contractures, increased frequency of bladder infections, decreased cardio-vascular capacity), can lead to decreased sensory–motor performance.

Medical devices are used to enhance the effects of electrical stimulation for restoring or assisting movement in humans with an injury/disease of the central nervous system. For example, deep brain stimulation is a remarkable therapy that has mainstreamed electrical stimulation of the brain for the treatment of neurological dysfunction.

  • Functional electrical stimulation (FES) was introduced as a method to artificially activate the sensory motor system after a CNS injury/disease and alleviate the resulting disability. Functional electrical stimulation is a powerful tool for inducing the contraction of paralyzed muscles.
Electrical Stimulation Devices Market

The global electrical stimulation devices market report provides market size ($million 2017 to 2027), market share, growth trends and forecast (CAGR% 2021 to 2027).

The global market for electrical stimulation products segmented by product [spinal cord stimulation (SCS) devices, deep brain stimulation (DBS) devices, vagus nerve stimulation (VNS) devices, sacral nerve stimulation (SNS) devices, gastric electrical stimulation (GES) devices, transcutaneous electrical nerve stimulation (TENS) devices, neuromuscular electrical stimulation (NMES/EMS) devices, and other devices (electrotherapy devices, combination devices, TNS, TMS)]; by application (pain management, neurological and movement disorder management, musculoskeletal disorder management, metabolism and GIT management, incontinence management, esthetics, training, wound healing, cosmetics) and geography.

  • Higher demand for stimulation therapies is attributed to rising incidence of neuromuscular disorders. Among the products segments, SCS devices accounted for the largest share of total market with moderate rate of growth throughout the forecast period.
  • The global spinal cord stimulation (SCS) devices market growth driven by growing elderly population, innovation in SCS therapies, fast advancing SCS applications and technologies. The SCS products segment growth also being supported by new product launches and increasing capital investment by manufactures in the recent years.
    • However, the vagus nerve stimulation products segment is expected to grow at a highest CAGR over the forecast period.
  • The pain management segment accounted for the largest share of the electrical stimulation devices market, mainly driven by increasing incidence of chronic back pain and sciatic pain among population, and due to its high effectiveness, rapid acceptance and adoption in physical therapy.
    • However, the neurological and movement disorder management products segment is anticipated to grow at a highest CAGR during the forecast period.

The global electrical stimulation products market research report is divided by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

  • Geographically, the growing incidence of low back pain and spinal injuries and increasing use of ESDs in sports medicine has triggered the demand for ESDs in the North America, Europe regions and the emerging markets.
    • However, the Asia Pacific region likely to register fastest CAGR over the forecast period, owing to growing prevalence of diseases such as diabetes, neuromuscular disease, and other co-morbid conditions.

The global electrical stimulation devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major competitors operating in the global market for ESD and included in this report are Abbott Laboratories, Inc., Boston Scientific Corporation, BTL Industries, Inc., Cyberonics, Inc., DJO Global, Inc., Medtronic plc, Nevro Corporation, NeuroMetrix, Inc., Uroplasty, Inc. (Cogentix Medical), and Zynex, Inc.

  • Product
    • Deep Brain Stimulation (DBS) Devices
    • Gastric Electrical Stimulation (GES) Devices
    • Neuromuscular Electrical Stimulation (NMES/EMS) Devices
    • Sacral Nerve Stimulation (SNS) Devices
    • Spinal Cord Stimulation (SCS) Devices
    • Transcutaneous Electrical Nerve Stimulation (TENS) Devices
    • Vagus Nerve Stimulation (VNS) Devices
    • Other Products (Electrotherapy Devices, Combination Devices, TNS, TMS)
  • Application
    • Incontinence Management
    • Metabolism & GIT Management
    • Musculoskeletal Disorder Management
    • Neurological and Movement Disorder Management
    • Pain Management
    • Others (esthetics, training, wound healing, cosmetics)
  • Geography
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World
  • Company Profiles
    • Abbott Laboratories, Inc.
    • Boston Scientific Corporation
    • BTL Industries, Inc.
    • Cyberonics, Inc.
    • DJO Global, Inc.
    • Medtronic plc
    • Nevro Corporation
    • NeuroMetrix, Inc.
    • Uroplasty, Inc. (Cogentix Medical)
    • Zynex, Inc.

To request Table of Contents and Sample Pages of this report visit:

Related publications:

    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]



    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: [email protected]